AXM Pharma, Inc. (AXMP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 18, 2025
Paramount Global Market Cap
AXM Pharma has a market cap or net worth of $1.04 million as of August 12, 2025.
Market Cap
1.04M
Enterprise Value
n/a
Revenue
110.68M
Ranking
n/a
PE Ratio
0.06
Stock Price
$0.00
Market Cap Chart
Since October 15, 2018, AXM Pharma's market cap has decreased from 206.09M to 1.04M, a decrease of -99.49%. That is a compound annual growth rate of -54.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 1.04M | 9,899.62% |
| Dec 30, 2022 | 10.41K | -99.50% |
| Dec 30, 2020 | 2.08M | 100.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |